Sebela Pharmaceuticals Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$11.8M
Doctors Paid
3,187
Transactions
7,750
2024 Total
$17.70
Payment Breakdown by Category
Research$11.2M (94.3%)
Consulting$551,979 (4.7%)
Food & Beverage$104,889 (0.9%)
Travel$15,479 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11.2M | 1,382 | 94.3% |
| Consulting Fee | $551,979 | 113 | 4.7% |
| Food and Beverage | $104,889 | 6,231 | 0.9% |
| Travel and Lodging | $15,479 | 23 | 0.1% |
| Grant | $500.00 | 1 | 0.0% |
Payments by Type
Research
$11.2M
1,382 transactions
General
$672,847
6,368 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability | $6.6M | 2 | 425 |
| A PHASE 3, PROSPECTIVE, MULTI-CENTER, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE VERACEPT, A LONG-ACTING REVERSIBLE INTRAUTERINE CONTRACEPTIVE FOR CONTRACEPTIVE EFFICACY, SAFETY, AND TOLERABILITY | $2.9M | 2 | 511 |
| SEB-ECP-202 | $448,938 | 0 | 28 |
| Evaluation of the Effectiveness, Safety and Tolerability of LevoCept Levonorgestrel-Releasing Intrauterine System for Long-Acting Reversible Contraception | $434,108 | 0 | 185 |
| EVALUATION OF THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF LEVOCEPT (LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM) FOR LONG-ACTING REVERSIBLE CONTRACEPTION | $286,494 | 0 | 132 |
| A Randomized, Single-Blind, Comparative Bioavailability Study to Assess the Pharmacokinetic Properties of VeraCept Intrauterine Contraceptive vs ParaGard in Healthy, Post-Menarcheal Women | $263,224 | 0 | 21 |
| Evaluation of the Effectiveness, Feasibility, Safety and Tolerability of the ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception | $167,673 | 0 | 49 |
| EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF LEVOCEPT | $32,560 | 0 | 10 |
| A RANDOMIZED, SINGLE-BLIND, COMPARATIVE BIOAVAILABILITY STUDY TO ASSESS THE PHARMACOKINETIC PROPERTIES OF VERACEPT INTRAUTERINE CONTRACEPTIVE VS PARAGARD IN HEALTHY, POST-MENARCHEAL WOMEN | $30,595 | 0 | 21 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Dr. James Boyer, M.d, M.D | Gastroenterology | New Haven, CT | $1,400 | $0 |
| Jessica Allegretti, M.d, M.D | Internal Medicine | Boston, MA | $1,375 | $0 |
| Dr. Angela Moore, Md, Pa, MD, PA | Dermatology | Arlington, TX | $1,101 | $0 |
| Dr. David Victor, M.d, M.D | Internal Medicine | Houston, TX | $1,100 | $0 |
| Dr. Tracey Vlahovic, Dpm, DPM | Podiatrist | San Francisco, CA | $1,069 | $0 |
| Brant Mccartan, Dpm, DPM | Podiatrist | Milwaukee, WI | $1,000 | $0 |
| Nicholas Anthony, Md, MD | Internal Medicine | Charlotte, NC | $1,000 | $0 |
| Annette Joyce,, Dpm, DPM | Podiatrist | Pawleys Island, SC | $1,000 | $0 |
| Dr. Phillip Ward, Dpm, DPM | Foot & Ankle Surgery | Fayetteville, NC | $1,000 | $0 |
| David Olson, Md, MD | Internal Medicine | Charlotte, NC | $1,000 | $0 |
| Baharak Moshiree, Md, MD | Internal Medicine | Charlotte, NC | $1,000 | $0 |
| Linda Stein Gold, M.d, M.D | Dermatology | West Bloomfield, MI | $1,000 | $0 |
| Dominic Andriacchi, Dpm, DPM | Podiatrist | Oak Lawn, IL | $776.44 | $0 |
| Dr. Zubaria Sarooj, D.p.m, D.P.M | Foot & Ankle Surgery | Hamden, CT | $586.59 | $0 |
| Unknown Provider | — | — | $550.00 | $0 |
| Jeffrey Jensen, Md, MD | Obstetrics & Gynecology | Portland, OR | $500.00 | $0 |
| Craig Elmets, Md, MD | Dermatology | Birmingham, AL | $500.00 | $0 |
| Dr. Raymond Cross, Md, MD | Gastroenterology | Baltimore, MD | $500.00 | $0 |
| Amit Merchea, Md, MD | Colon & Rectal Surgery | Jacksonville, FL | $400.00 | $0 |
| Dr. Marina Zabezhanskaya, M.d, M.D | Dermatology | Brooklyn, NY | $376.53 | $0 |
| Dr. Kevin Molan, Dpm, DPM | Primary Podiatric Medicine | Charlotte, NC | $344.02 | $0 |
| Dr. Khristine Sparta, Dpm, DPM | Foot & Ankle Surgery | North Haven, CT | $342.09 | $0 |
| Bruce Strober, M.d, M.D | Dermatology | Cromwell, CT | $325.00 | $0 |
| Dr. Rory Panepinto, Md, MD | Podiatrist | Metairie, LA | $318.45 | $0 |
| Abraham Yale, D.p.m, D.P.M | Foot & Ankle Surgery | Fairfield, CT | $295.20 | $0 |
About Sebela Pharmaceuticals Inc.
Sebela Pharmaceuticals Inc. has made $11.8M in payments to 3,187 healthcare providers, recorded across 7,750 transactions in the CMS Open Payments database. In 2024, the company paid $17.70. The top product by payment volume is NAFTIN ($71,054).
Payments were distributed across 78 medical specialties. The top specialty by payment amount is Obstetrics & Gynecology ($717,074 to 264 doctors).
Payment categories include: Food & Beverage ($104,889), Consulting ($551,979), Research ($11.2M), Travel & Lodging ($15,479).
Sebela Pharmaceuticals Inc. is associated with 3 products in the CMS Open Payments database.